CA1026670A - Injectable composition containing sulphonamides and potentiator therefor - Google Patents

Injectable composition containing sulphonamides and potentiator therefor

Info

Publication number
CA1026670A
CA1026670A CA209,971A CA209971A CA1026670A CA 1026670 A CA1026670 A CA 1026670A CA 209971 A CA209971 A CA 209971A CA 1026670 A CA1026670 A CA 1026670A
Authority
CA
Canada
Prior art keywords
composition containing
injectable composition
sulphonamides
potentiator
therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA209,971A
Other languages
English (en)
French (fr)
Other versions
CA209971S (en
Inventor
Karl Rumpf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of CA1026670A publication Critical patent/CA1026670A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA209,971A 1973-09-24 1974-09-23 Injectable composition containing sulphonamides and potentiator therefor Expired CA1026670A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB44679/73A GB1485382A (en) 1973-09-24 1973-09-24 Injectable therapeutic compositions

Publications (1)

Publication Number Publication Date
CA1026670A true CA1026670A (en) 1978-02-21

Family

ID=10434320

Family Applications (1)

Application Number Title Priority Date Filing Date
CA209,971A Expired CA1026670A (en) 1973-09-24 1974-09-23 Injectable composition containing sulphonamides and potentiator therefor

Country Status (18)

Country Link
US (1) US4089949A (de)
JP (1) JPS5411363B2 (de)
BE (1) BE820235A (de)
CA (1) CA1026670A (de)
CS (1) CS209473B2 (de)
CY (1) CY1057A (de)
DE (1) DE2445400C3 (de)
DK (1) DK137594B (de)
ES (1) ES430307A1 (de)
FI (1) FI53069C (de)
FR (1) FR2244533B1 (de)
GB (1) GB1485382A (de)
HU (1) HU168150B (de)
IL (1) IL45704A (de)
IT (1) IT1050665B (de)
NL (1) NL170368C (de)
SE (1) SE429817B (de)
ZA (1) ZA746023B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212498B (en) 1992-11-06 1996-07-29 Egyt Gyogyszervegyeszeti Gyar Process for producing water-soluble pharmaceutical compositions, containing sulfachlorpyridazin-sodium and trimethoprim
US6211185B1 (en) 1999-05-05 2001-04-03 Veterinary Pharmacy Corporation Concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution, and a suspending agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895874A (en) * 1953-03-27 1959-07-21 Whitmoyer Lab Inc Diamino-pyrimidine compositions for chemotherapy of coccidiosis
CH544053A (de) * 1966-05-09 1973-11-15 Hoffmann La Roche Verfahren zur Herstellung von Sulfonamidderivaten
US3507952A (en) * 1968-12-20 1970-04-21 Smithkline Corp Sustained release bolus for animal husbandry
US3985876A (en) * 1973-01-05 1976-10-12 Burroughs Wellcome Co. Chemotherapeutic solutions containing a sulphur and a salt of a 2,4-diamino-5-benzylpyrimidine
US3985873A (en) * 1973-12-27 1976-10-12 Burroughs Wellcome Co. Solution containing trimethoprim, sulfacetamide and polymyxin

Also Published As

Publication number Publication date
SE7411917L (de) 1975-03-25
NL170368C (nl) 1982-11-01
NL170368B (nl) 1982-06-01
FR2244533A1 (de) 1975-04-18
AU7359674A (en) 1976-03-25
FI53069B (de) 1977-10-31
FI276374A (de) 1975-03-24
HU168150B (de) 1976-02-28
CS209473B2 (en) 1981-12-31
DK499074A (de) 1975-05-26
IT1050665B (it) 1981-03-20
IL45704A0 (en) 1974-11-29
US4089949A (en) 1978-05-16
CY1057A (en) 1980-08-01
DK137594B (da) 1978-04-03
DK137594C (de) 1978-09-25
FR2244533B1 (de) 1978-06-30
JPS5411363B2 (de) 1979-05-15
JPS5088217A (de) 1975-07-15
IL45704A (en) 1977-10-31
DE2445400A1 (de) 1975-04-03
DE2445400C3 (de) 1982-01-07
NL7412511A (nl) 1975-03-26
ZA746023B (en) 1976-04-28
DE2445400B2 (de) 1980-12-04
SE429817B (sv) 1983-10-03
ES430307A1 (es) 1977-02-16
GB1485382A (en) 1977-09-08
BE820235A (fr) 1975-03-24
FI53069C (de) 1978-02-10

Similar Documents

Publication Publication Date Title
CA1019080A (en) Stabilized polyester compositions
CA1029153A (en) Bleaching composition and methods
CA1020682A (en) Asphalt composition
CA994351A (en) Tetrahydronaphthyloxy-amines and related compounds
CA1019908A (en) Warp-sizing compositions and yarns sized therewith
CA1018555A (en) Semi-gloss glaze composition
AU471979B2 (en) Binder composition
CA1033667A (en) Composition containing sulphonamide
CA1026670A (en) Injectable composition containing sulphonamides and potentiator therefor
CA1027291A (en) Polyamide-imide composition
CA1026671A (en) Injectable composition containing sulphonamides and potentiator thereof
CA969114A (en) Container construction and parts therefor
CA1001532A (en) Borlding compositions and methods
CA1025892A (en) Refractory composition
CA1033868A (en) Polyester composition
AU462400B2 (en) 11-substituted -11-desoxy-pge and p-pfg analogues
CA1026674A (en) Anesthetic composition
CA1022546A (en) P-glu-d-phe-trp-ser-tyr-d-ala-leu-arg-pro-gly-nh2 p-glu-d-phe-trp-ser-tyr-d-leu-leu-arg-pro-gly-nh2 and intermediates
AU472354B2 (en) Rotational molding and composition therefor
AU483466B2 (en) Improved silo construction
AU5381373A (en) Container construction and parts therefor
CA989157A (en) Acidizing composition
AU487864B2 (en) Improved llubricant composition
AU488834B2 (en) Local anesthetic composition
CA1006413A (en) Purifying composition and its application